These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39176668)

  • 1. Preferences for Injection Device Settings and the Association with Adherence to Growth Hormone Treatment in Patient with Growth Disorders.
    van Dommelen P; Rivera-Romero O; Arnaud L; Zucchiatti C; Koledova E
    Stud Health Technol Inform; 2024 Aug; 316():38-42. PubMed ID: 39176668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
    Maggio MC; Vergara B; Porcelli P; Corsello G
    Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participatory Study to Explore Healthcare Professionals' Perceptions of a Connected Digital Solution for Adherence Monitoring of Recombinant Human Growth Hormone Treatment: Study Protocol and First Findings.
    Rivera-Romero O; Felicia Faienza M; Vergani E; Zucchiatti C; Koledova E
    Stud Health Technol Inform; 2023 May; 302():23-27. PubMed ID: 37203602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of connected injection device has a positive effect on catch-up growth in patients with growth disorders treated with growth hormone therapy.
    de Arriba A; van Dommelen P; Savage MO
    Front Endocrinol (Lausanne); 2024; 15():1450573. PubMed ID: 39429736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yearly Height Gain Is Dependent on the Truly Received Dose of Growth Hormone and the Duration of Periods of Poor Adherence: Practical Lessons From the French Easypod™ Connect Multicenter Observational Study.
    Coutant R; Nicolino M; Cammas B; de Buyst V; Tauber M; Hamel JF
    Front Endocrinol (Lausanne); 2021; 12():790169. PubMed ID: 35126310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to Growth Hormone Treatment Using a Connected Device in Latin America: Real-World Exploratory Descriptive Analysis Study.
    Assefi A; van Dommelen P; Arnaud L; Otero C; Fernandez-Luque L; Koledova E; Calliari LE
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e32626. PubMed ID: 35049518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved adherence and growth outcomes with jet-delivered growth hormone.
    Michaelidou M; Whitten S; Bajaj P; Knight A; Spoudeas HA
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):207-213. PubMed ID: 30844762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.
    Brearley C; Priestley A; Leighton-Scott J; Christen M
    BMC Clin Pharmacol; 2007 Oct; 7():10. PubMed ID: 17922895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders.
    Hartmann K; Ittner J; Müller-Rossberg E; Schönau E; Stephan R; Ullrich KP; Hoppe B; Ramseger R; Brämswig J
    Horm Res Paediatr; 2013; 80(1):1-5. PubMed ID: 23860437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS).
    Charmandari E; Vlachopapadopoulou E; Kyritsi EM; Sakellariou D; Koledova E; Nespithal K; Michalacos S
    Growth Horm IGF Res; 2020; 53-54():101336. PubMed ID: 32739654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patients.
    Kappelgaard AM; Mikkelsen S; Knudsen TK; Fuchs GS
    J Pediatr Endocrinol Metab; 2011; 24(7-8):489-96. PubMed ID: 21932587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of real-world data on growth hormone therapy adherence using a connected injection device.
    Koledova E; Tornincasa V; van Dommelen P
    BMC Med Inform Decis Mak; 2020 Jul; 20(1):176. PubMed ID: 32727461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the TUITEK
    Assefi AR; Graham S; Crespo ML; Debicki M; Reston J; Gonzalez J; Jheeta A; Koledova E
    Front Endocrinol (Lausanne); 2023; 14():1129385. PubMed ID: 37091843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of machine learning to identify patients at risk of sub-optimal adherence: study based on real-world data from 10,929 children using a connected auto-injector device.
    Spataru A; van Dommelen P; Arnaud L; Le Masne Q; Quarteroni S; Koledova E
    BMC Med Inform Decis Mak; 2022 Jul; 22(1):179. PubMed ID: 35794586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial patient choice of a growth hormone device improves child and adolescent adherence to and therapeutic effects of growth hormone replacement therapy.
    Gau M; Takasawa K
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):989-993. PubMed ID: 28771439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed methods feasibility study.
    Stokes H; Jones J; Worth C; Nicholson J; Fullwood C; Banerjee I
    Front Endocrinol (Lausanne); 2023; 14():1167854. PubMed ID: 37324260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use.
    Dahlgren J; Veimo D; Johansson L; Bech I
    Curr Med Res Opin; 2007 Jul; 23(7):1649-55. PubMed ID: 17559757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.